|
|
 |
|
Viewing report
|
|
|
|
Astellas Pharma Inc.: SWOT Analysis & Company Profile
Business Review, Aug 2010, Pages: 25
Synopsis
Business Review’s Astellas Pharma Inc. contains a company overview, key facts, locations and subsidiaries, news and events as well as a SWOT analysis of the company.
Summary
This SWOT Analysis company profile is a crucial resource for industry executives and anyone looking to quickly understand the key information concerning Astellas Pharma Inc.’s business.
Business Review’s “Astellas Pharma Inc. SWOT Analysis & Company Profile” reports utilize a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format.
Business Review strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Scope
- Examines and identifies key information and issues about (Astellas Pharma Inc.) for business intelligence requirements
- Studies and presents Astellas Pharma Inc.’s strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
- The profile contains business operations, the company history, major products and services, prospects, key competitors, structure and key employees, locations and subsidiaries.
Reasons To Buy
- Quickly enhance your understanding of the company.
- Obtain details and analysis of the market and competitors as well as internal and external factors which could impact the industry.
- Increase business/sales activities by understanding your competitors’ businesses better.
- Recognize potential partnerships and suppliers.
- Obtain yearly profitability figures
Key Highlights
Astellas Pharma Inc. (Astellas) is a global pharmaceutical company engaged in developing, manufacturing and marketing of pharmaceuticals and related products. The company has superior research and development capabilities to develop new drugs, manufacturing facilities for the manufacturing of products in a cost effective way and efficient in-house sales force to market those products. Its global major products are Prograf, Vesicare, Protopic, Harnal and Funguard. The company is one of the leading pharmaceutical manufacturers providing products for Urology, transplantation and Oncology fields. Apart from Japan, Astellas supplies its products to global markets, including Ireland, the UK, Netherlands, China, Hong Kong, Thailand, Indonesia, Philippines, etc. The company is headquartered at Chuo-Ku in Tokyo, Japan.
|
|
|
|
